Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 25, 2006
Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancerQing-an Yuan, Heidi H Simmons, Matthew K Robinson, et al.Molecules (Basel, Switzerland)|December 22, 2016
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule AgentsShilpa Chooniedass, Rachelle L Dillon, Arjune Premsukh, et al.Plos One|April 25, 2013
Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinomaPeirong Chen, Shoko Nogusa, Roshan J Thapa, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2006
Affibody-mediated tumour targeting of HER-2 expressing xenografts in miceAnn-Charlott Steffen, Anna Orlova, Maria Wikman, et al.Journal of Molecular Biology|July 3, 2007
Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cellsYu Zhou, Daryl C Drummond, Hao Zou, et al.Nuclear Medicine and Biology|August 21, 2007
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody moleculeErika Nordberg, Mikaela Friedman, Lovisa Göstring, et al.Cancer Research|March 1, 2005
Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabodyMatthew K Robinson, Mohan Doss, Calvin Shaller, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scannerDinko E González Trotter, Ravindra M Manjeshwar, Mohan Doss, et al.Analytical Chemistry|April 1, 2011
Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantileversLiNa Loo, Joseph A Capobianco, Wei Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimersGregory P Adams, Mei-Sheng Tai, John E McCartney, et al.Pageof 5